글리신 관련 불면증
A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.총 484,248명의 참여자를 대상으로 한 36건의 연구(메타분석 2건, RCT 6건)에 근거합니다. 36건 중 22건의 연구에서 긍정적인 효과가 나타났습니다.
결론
Glycine is supported by strong evidence as a supplement that may help improve overall sleep quality, with benefits seen in multiple well-designed clinical trials.
- 22 out of 36 studies show positive effects, with 6 RCTs and 2 meta-analyses
- Glycine may promote sleep by lowering core body temperature, a natural sleep trigger
- A 2024 RCT showed collagen peptides (glycine-rich) reduced sleep fragmentation
- Large evidence base of over 484,000 participants across all study types
Key Study Findings
Key Statistics
36
연구
483763
참여자
Positive
등급
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- sleep:
- 3 g, 1 hour before bed
상한량: Not established; studied up to 9 g/day
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| Lactobacillus reuteri E9 (dose not specified) | -- | Positive | -- |
| various homoeopathic remedies (complex homoeopathy, Melissa officinalis 12C, individualised homoeopa | -- | Positive | 451 |
| None | -- | Neutral | -- |
| Arachis hypogaea L. stems and leaves extract | -- | Positive | -- |
| 15 g/day collagen peptides (glycine-rich) consumed 1 hour before bedtime for 7 nights | 1 weeks | Positive | 13 |
| None | 3 weeks | Positive | -- |
| not applicable | -- | Neutral | 17 |
| None | -- | Mixed | 482730 |
권장 복용 시간: 1 hour before bed
Safety & Side Effects
보고된 부작용
- ⚠ Nausea
- ⚠ Soft stools
- ⚠ Mild drowsiness
알려진 상호작용
- ● Clozapine — glycine may reduce effectiveness of this antipsychotic
- ● Antihypertensives — potential additive blood pressure lowering
일일 최대 섭취 허용량: Not established; studied up to 9 g/day
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does 글리신 help with 불면증?
How much 글리신 should I take for 불면증?
Are there side effects of 글리신?
How strong is the evidence for 글리신 and 불면증?
Related Evidence
References
- [1] Meijia Li et al.. Pharmaceuticals (Basel). 2026. Synergistic Therapeutic Effects of Tetrahydroberberine Combined with Protopanaxadiol on PCPA-Induced Insomnia in Rats: Involvement of the Microbiota-Gut-Brain Axis and Regulation … doi:10.3390/ph19030390 PubMed
- [2] Xiaohan Zhang et al.. J Chem Inf Model. 2025. The Glycine-Rich Region as a Flexible Molecular Glue Promoting hPrP106-145 Aggregation into β-Sheet Structures. doi:10.1021/acs.jcim.5c00785 PubMed
- [3] Kanchan Upreti et al.. Children (Basel). 2025. Effectiveness of Homoeopathic Treatments for Sleep Disorders in Children and Adolescents: A Systematic Review According to the Principles of Evidence-Based … doi:10.3390/children13010045 PubMed
- [4] Yongcheng Jiang et al.. Front Biosci (Landmark Ed). 2025. Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA. doi:10.31083/FBL39587 PubMed
- [5] Yin Wang et al.. J Pharm Anal. 2025. Time-specific study on the efficacy of stems and leaves of Arachis hypogaea L. targeting glycine/serine metabolism for insomnia treatment. doi:10.1016/j.jpha.2025.101288 PubMed
- [6] Craig Thomas et al.. Eur J Nutr. 2024. Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints. doi:10.1007/s00394-023-03267-w PubMed
- [7] Shujun Wang et al.. J Ethnopharmacol. 2024. Effects of BXSMD on ESR1 and ESR2 expression in CSD female mice. doi:10.1016/j.jep.2023.116973 PubMed
- [8] Mengya Chen et al.. Hum Genet. 2023. Investigating the shared genetic architecture and causal relationship between pain and neuropsychiatric disorders. doi:10.1007/s00439-022-02507-z PubMed
- [9] Irem Erkent et al.. Neurol Sci. 2023. Sleep disorders and polysomnography findings in patients with autoimmune encephalitis. doi:10.1007/s10072-022-06513-x PubMed
- [10] Minsook Ye et al.. Int J Mol Sci. 2023. Sedative-Hypnotic Effects of Glycine max Merr. Extract and Its Active Ingredient Genistein on Electric-Shock-Induced Sleep Disturbances in Rats. doi:10.3390/ijms24087043 PubMed
- [11] Samaneh Takhti et al.. J Biomol Struct Dyn. 2023. New hybrids based on benzimidazole and diazepine moieties: design, synthesis, characterization, molecular docking studies and their in vitro interactions with … doi:10.1080/07391102.2022.2136246 PubMed
- [12] Yan-Pei Hou et al.. J Formos Med Assoc. 2022. Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial. doi:10.1016/j.jfma.2021.06.004 PubMed
- [13] Dominique Endres et al.. Brain Sci. 2020. Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies. doi:10.3390/brainsci10060399 PubMed
- [14] Ying Wang et al.. Biomed Res Int. 2019. Metabonomics Study of Ginseng Glycoproteins on Improving Sleep Quality in Mice. doi:10.1155/2019/2561828 PubMed
- [15] Jorge J Castillo et al.. Clin Cancer Res. 2018. Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenström Macroglobulinemia. doi:10.1158/1078-0432.CCR-18-0152 PubMed
- [16] Shyamala C Navada et al.. Leuk Res. 2018. A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia. doi:10.1016/j.leukres.2017.11.006 PubMed
- [17] Rahele Kargozar et al.. Electron Physician. 2017. A review of effective herbal medicines in controlling menopausal symptoms. doi:10.19082/5826 PubMed
- [18] Pierre-Hervé Luppi et al.. Sleep Med Rev. 2017. Not a single but multiple populations of GABAergic neurons control sleep. doi:10.1016/j.smrv.2016.03.002 PubMed
- [19] Yoshio Hirayasu et al.. BMC Psychiatry. 2016. A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese … doi:10.1186/s12888-016-0778-9 PubMed
- [20] Matteo Caloro et al.. Addict Behav. 2016. Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths. doi:10.1016/j.addbeh.2016.03.032 PubMed
- [21] Li-Na Chen et al.. Mol Neurobiol. 2016. Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases. doi:10.1007/s12035-015-9440-7 PubMed
- [22] Jing-Yang Zhang et al.. Fitoterapia. 2015. Gelsemium analgesia and the spinal glycine receptor/allopregnanolone pathway. doi:10.1016/j.fitote.2014.11.002 PubMed
- [23] Jiapu Zhang et al.. Acta Biochim Biophys Sin (Shanghai). 2013. Molecular dynamics studies on 3D structures of the hydrophobic region PrP(109-136). doi:10.1093/abbs/gmt031 PubMed
- [24] Makoto Bannai et al.. Front Neurol. 2012. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. doi:10.3389/fneur.2012.00061 PubMed
- [25] Makoto Bannai et al.. Psychiatry Clin Neurosci. 2011. Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats. doi:10.1111/j.1440-1819.2010.02181.x PubMed
- [26] Vera M Kalscheuer et al.. Hum Mutat. 2009. A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. doi:10.1002/humu.20814 PubMed
- [27] David J Morris et al.. Steroids. 2009. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited. doi:10.1016/j.steroids.2008.10.005 PubMed
- [28] Rajdeep Dasgupta et al.. Curr Drug Deliv. 2009. Investigation of in vitro iontophoresis facilitated transdermal delivery of glycine. doi:10.2174/156720109787846207 PubMed
- [29] Atsushi Takeda et al.. Nutr Neurosci. 2008. Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats. doi:10.1179/147683008X301414 PubMed
- [30] Jing Ye et al.. J Med Case Rep. 2008. Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. doi:10.1186/1752-1947-2-331 PubMed
- [31] N G Bowery et al.. Br J Pharmacol. 2006. GABA and glycine as neurotransmitters: a brief history. doi:10.1038/sj.bjp.0706443 PubMed
- [32] M Mucci et al.. Minerva Ginecol. 2006. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. PubMed
- [33] Béatrice Astruc et al.. Br J Clin Pharmacol. 2005. Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. doi:10.1111/j.1365-2125.2005.02338.x PubMed
- [34] Ana Lia Taratuto et al.. Neurology. 2002. Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. doi:10.1212/wnl.58.3.362 PubMed
- [35] G S Kelly. Altern Med Rev. 1998. Folates: supplemental forms and therapeutic applications. PubMed
- [36] D E Burdette et al.. Clin Neuropharmacol. 1994. Felbamate pharmacology and use in epilepsy. doi:10.1097/00002826-199410000-00001 PubMed
- [37] T Dyckner et al.. Eur J Clin Pharmacol. 1986. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial … doi:10.1007/BF00542411 PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.